Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis

Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis have?

Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis has 21 citations in the OpenAlex counts ScholarIQ stores.

When was Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis published?

Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis has 2022 year in the ScholarIQ index.

What is the open-access status of Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis?

Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis has gold oa status in the ScholarIQ index.

What is the DOI of Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis?

The DOI for Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis is on the source record.

What is the PMID of Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis?

The PMID for Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis is on the source record.

What is the OpenAlex record for Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis?

The OpenAlex for Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis is on the source record.